首頁 > 市場調查報告書 > 製藥

動物用醫藥

伴侶動物保健市場規模、佔有率和成長分析（按產品類型、動物種類、最終用戶、通路和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900087

伴侶動物保健市場規模、佔有率和成長分析（按產品類型、動物種類、最終用戶、通路和地區分類）－2026-2033年產業預測

Companion Animal Healthcare Market Size, Share, and Growth Analysis, By Product Type (Pharmaceuticals, Vaccines), By Animal Type (Dogs, Cats), By End User, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，伴侶動物保健市場規模將達到 273.8 億美元，到 2025 年將達到 296.8 億美元，到 2033 年將達到 565.9 億美元，在預測期（2026-2033 年）內複合年成長率為 8.4%。

遠距辦公的普及顯著推動了寵物飼養量的成長，因為人們尋求陪伴來對抗社交隔離帶來的憂鬱和焦慮。調查顯示，寵物在家庭生活中佔據重要地位，相當多的家庭都飼養寵物。癌症發生率的上升，尤其是在犬類中，預計將進一步推動寵物醫療保健市場的成長，凸顯了對更完善的獸醫服務和治療方法的需求。同時，寵物飼養量的成長也促使企業採取策略性舉措，以擴大其在動物醫療保健領域的市場佔有率。這些舉措，包括收購，有望改善人們獲得高品質獸醫服務的途徑，並促進該行業的永續發展。

伴侶動物保健市場促進因素

全球寵物飼養量的持續成長是伴侶動物醫療保健市場發展的關鍵驅動力。隨著越來越多的人選擇將寵物作為伴侶融入生活，對包括獸醫護理、疫苗接種和健康維護產品在內的醫療保健服務的需求也隨之上升。寵物飼養量的激增歸因於多種因素，包括城市生活、生活方式的改變以及人們對寵物飼養益處的認知不斷提高。因此，對伴侶動物專業醫療保健解決方案的需求持續成長，這反映了人類與動物關係的變化以及人們對寵物健康的日益重視。

伴侶動物保健市場限制因素

伴侶動物醫療保健市場面臨的主要限制因素之一是獸醫服務費用高昂。雖然先進的治療方法可以顯著改善動物的健康狀況，但其高昂的費用給許多飼主帶來了沉重的經濟負擔。這種經濟障礙會限制寵物主人獲得必要的醫療保健服務，尤其對於中低收入飼主，最終可能導致寵物無法獲得全面的健康解決方案。因此，許多飼主難以負擔必要的治療費用，這可能導致醫療資源利用不足，並可能降低動物的整體福祉。

伴侶動物醫療保健市場趨勢

伴侶動物醫療保健市場正經歷著一個顯著的趨勢：寵物保險的普及率不斷提高。這主要歸因於飼主對寵物保險經濟效益的意識提升不斷增強以及獸醫護理成本的不斷上漲。隨著飼主希望在不造成過重經濟負擔的情況下改善寵物的健康狀況，對全面保險的需求日益成長。這種轉變不僅顯示人們對負責任的寵物飼養意識不斷增強，也預示著一種文化轉變，即人們更加重視伴侶動物的健康和福祉，從而塑造寵物醫療保健服務的未來。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Zoetis Inc.
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
Elanco Animal Health Incorporated
Bayer AG
Ceva Sante Animale
Virbac
Vetoquinol SA
Heska Corporation
IDEXX Laboratories, Inc.
Dechra Pharmaceuticals PLC
Phibro Animal Health Corporation
Ourofino Saude Animal
Neogen Corporation
Ceva Animal Health LLC

結論與建議

簡介目錄

Product Code: SQMIG35E2026

Companion Animal Healthcare Market size was valued at USD 27.38 Billion in 2024 and is poised to grow from USD 29.68 Billion in 2025 to USD 56.59 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The trend towards remote work has significantly contributed to an increase in pet adoption, as individuals seek companionship to combat feelings of depression and anxiety stemming from social isolation. Research indicates a notable presence of companion animals in households, with a substantial portion of households owning pets. The prevalence of cancer, particularly among dogs, is anticipated to further propel market growth in companion animal healthcare, emphasizing the need for enhanced veterinary services and treatments. Alongside this, the rising trend of pet ownership has prompted companies to pursue strategic initiatives to expand their market share in animal healthcare. Such initiatives, including acquisitions, are expected to improve access to advanced veterinary facilities, thereby fostering continued growth within the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Companion Animal Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Companion Animal Healthcare Market Segments Analysis

Global Companion Animal Healthcare Market is segmented by product type, animal type, end user, distribution channel and region. Based on product type, the market is segmented into pharmaceuticals (antibiotics, anti-inflammatory drugs, parasiticides, pain management, others), vaccines (live attenuated vaccines, inactivated vaccines, recombinant vaccines, others), diagnostics (immunodiagnostic tests, molecular diagnostics, diagnostic imaging, clinical chemistry, others) and feed additives (nutritional feed additives, medicinal feed additives). Based on animal type, the market is segmented into dogs, cats, horses and other. Based on end user, the market is segmented into veterinary hospitals & clinics, diagnostic laboratories, research institutes and home care settings. Based on distribution channel, the market is segmented into Hospital Pharmacies, retail pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Companion Animal Healthcare Market

The rising trend of pet ownership worldwide serves as a significant catalyst for the Companion Animal Healthcare market. As individuals increasingly choose to welcome pets into their lives for companionship, there is a growing need for health-related services, including veterinary care, vaccinations, and wellness products. This surge in pet adoption can be attributed to various factors, such as urban living, evolving lifestyles, and heightened awareness of the advantages associated with having pets. Consequently, the demand for healthcare solutions tailored to companion animals continues to expand, reflecting the shifting dynamics of human-animal relationships and the prioritization of pets' well-being.

Restraints in the Companion Animal Healthcare Market

One significant limitation within the Companion Animal Healthcare market is the elevated cost of veterinary services. While advanced medical treatments and procedures can significantly improve animal health, their high expenses create a financial burden for many pet owners. This economic barrier can restrict access to essential healthcare, particularly for those with lower to moderate incomes, ultimately hindering the provision of comprehensive health solutions for their pets. As a result, many pet owners may struggle to afford necessary treatments, leading to underutilization of healthcare resources and a potential decline in overall animal well-being.

Market Trends of the Companion Animal Healthcare Market

The companion animal healthcare market is experiencing a notable trend towards the increasing adoption of pet insurance, driven by a combination of heightened awareness among pet owners regarding the financial benefits of such policies and the escalating costs associated with veterinary care. As pet owners seek to enhance their pets' well-being without incurring substantial financial burdens, the demand for comprehensive insurance coverage is on the rise. This shift not only reflects a growing commitment to responsible pet ownership but also signifies a broader cultural change towards prioritizing the health and wellness of companion animals, thereby shaping the future landscape of pet healthcare services.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis
Case Studies

Global Companion Animal Healthcare Market Size by Product Type & CAGR (2026-2033)

Market Overview
Pharmaceuticals
- Antibiotics
- Anti-inflammatory Drugs
- Parasiticides
- Pain Management
- Others
Vaccines
- Live Attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Others
Diagnostics
- Immunodiagnostic Tests
- Molecular Diagnostics
- Diagnostic Imaging
- Clinical Chemistry
- Others
Feed Additives
- Nutritional Feed Additives
- Medicinal Feed Additives

Global Companion Animal Healthcare Market Size by Animal Type & CAGR (2026-2033)

Market Overview
Dogs
Cats
Horses
Other

Global Companion Animal Healthcare Market Size by End User & CAGR (2026-2033)

Market Overview
Veterinary Hospitals & Clinics
Diagnostic Laboratories
Research Institutes
Home Care Settings

Global Companion Animal Healthcare Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Companion Animal Healthcare Market Size & CAGR (2026-2033)

North America (Product Type, Animal Type, End User, Distribution Channel, Distribution Channel)
- US
- Canada
Europe (Product Type, Animal Type, End User, Distribution Channel)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific (Product Type, Animal Type, End User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America (Product Type, Animal Type, End User, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Animal Type, End User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Zoetis Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elanco Animal Health Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ceva Sante Animale
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virbac
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vetoquinol S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Heska Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IDEXX Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dechra Pharmaceuticals PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phibro Animal Health Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ourofino Saude Animal
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neogen Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ceva Animal Health LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments